Recognition hyperinsulinemia as the root cause of type 2 diabetes mellitus is becoming more supporters. The overload nutrition cell and insulin resistance is developing as a result of hyperinsulinemia. Insulin resistance is not the only one protection mechanism. Functional system to limited excessive insulin action includes other mechanisms. This review describes the reactions that develop in the tissues in diabetic patients and their relationship with excessive exposure to insulin. Negative feedback mechanism under excessive stimulation of insulin action includes action contrainsular hormones, no β-cell response on increasing the glucose in the extracellular medium, reduction of C-peptide, induction of β-cell apoptosis. The compensation mechanisms includes the restriction of consumption of substances and flow of information, the redirecting excess in the adi-pose tissue, the glycogen synthesis and the activation of kinase-3 synthase glycogen. The conditions GI insulin is able to bind and activate receptors IGF-type 1 to a greater extent than insulin receptors. At diabetes the repro-duction, the growth and the differentiation of cells are accelerated, leading to tumor growth, the accumulation of senescent cells. The depletion and reduction of telomerase activity in diabetes mellitus also have an adaptive value. Contact with receptors undifferentiated cells caused by their high sensitivity and low capacity for insulin resistance, operates referral mechanism power is the same as for obesity. Young cells of functionally active or-gans die, some cells accelerate differentiation and less active peripheral located in hypoxic conditions, may be-come cancerous. The author believes that the growth of tumors after intensive treatment of diabetes is associated with excess insulin action.
type 2 diabetes, excessive adaptation to the effects of insulin, reducing the activity of islet cells, obesity, deposition of glycogen, reproduction, growth and differentiation of tissues, aging, cancer.
1. β-kletka: sekretsiya insulina v norme i patologii. Moskva, 2009. 156 s.
2. Anisimov V.N. Molekulyarnye i fiziologicheskie mekhanizmy stareniya. Sankt-Peterburg: «Nauka» RAN, 2003. 468 s.
3. Bershteyn L.M., Vasil´ev D.A., Tsyrlina E.V., Boyarkina M.P., Semenova N.V., Merabishvi-li V.M., Ulybina Yu.M., Bratchikov E.V. Sakharnyy diabet u onkologicheskikh bol´nykh: Kak eto vliyaet na ikh lechenie i ego rezul´taty?. X Rossiyskiy onkologicheskiy kongress: materialy kongressa 21-23 noyabrya 2006 goda. Moskva, 2006. S. 32-35.
4. Bol´shaya meditsinskaya entsiklopediya. Gipotireoz - Degeneratsiya. 3-e izd. Pod red. Petrovsko-go B.V. M.: Sovetskaya entsiklopediya, 1976. T. 6. 609 s.
5. Dedov I.I., Butrova S.A., Berkovskaya M.A. Potentsial´nye vozmozhnosti metformina v profilaktike i lechenii onkologicheskikh zabolevaniy u bol´nykh sakharnym diabetom 2 tipa. Ozhirenie i metabolizm. 2011. №1. S. 40-48.
6. Drygin A.N., Shustov S.B., Pastushenkov V.L. Sostoyanie neyrogormonal´noy regulyatsii i metabolizma u bol´nykh s sakharnym diabetom i aterosklerozom. Mediko-biologicheskie i sotsial´no-psikhologicheskie problemy bezopasnosti v chrezvychaynykh situatsiyakh. 2010. №3. S. 48-53
7. Dudinskaya E.N., Brailova N.V., Strazhesko I.D., Akasheva D.U., Tkacheva O.N., Shestakova M.V. Rol´ insulinorezistentnosti v protsessakh sosudistogo stareniya (obzor literatury). Profilakticheskaya meditsina. 2014. №2. S. 35-41.
8. Ivanova S.A., Losenkov I.S., Bokhan N.A. Rol´ kinazy glikogensintazy-3β v patogeneze psikhicheskikh rasstroystv. Zhurnal nevrologii i psikhiatrii. 2014. №6. S. 93-100.
9. Kasatkina E.P. Sakharnyy diabet u detey. Izdanie 1-e. M.: Meditsina, 1990. 272 s.
10. Kikteva R.N., Peterkova V.A. Osobennosti sekretsii insulina i dinamika antropometricheskikh pokazateley pri razlichnykh tipakh ozhireniya. Sakharnyy diabet. 2003. T.6, №4. S. 18-21.
11. Kolychev A.P., Ternovskaya E.E. Razlichiya dinamiki internalizatsiiretseptorov insulina i insulinopodobnogo rosta I (IRF-I) retseptorov v izolirovannykh gepatotsitakh krysy. Zhurnal evolyutsionnoy biokhimii i fiziologii. 2013. T. 49, № 6. S. 433-442.
12. Kochergina I.I., Dolgopolaya I.V. Issledovanie leptina i insulina pri ozhirenii. Sbornik tezisov VII Vserossiyskogo diabetologicheskogo kongressa. Moskva, 2015. S. 237.
13. Makisheva R.T., Abilkasimov A.A. Sakharnyy diabet - bolezn´ adaptatsii k giperinsulinizmu. International jornal on immunoreabilitotin. 1997. №4. S. 390.
14. Makisheva R.T. Insulin i kletochnaya smert´. Vestnik novykh meditsinskikh tekhnologiy (elektronnoe izdanie). 2015. №2. Publikatsiya 2-4. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2015-2/5122.pdf (data obrashcheniya 17.04.15). DOIhttps://doi.org/10.12737/10812.
15. Makisheva R.T. Prisposobitel´noe povedenie belykh krys s ekzogennoy giperinsulinemiey na fone immobilizatsionnogo stressa, pishchevoy i vodnoy deprivatsii : Avtoreferat dissertatsii kand. med. nauk. Moskva, 1997.
16. Makisheva R.T. Fiziologiya sakharnogo diabeta. Monografiya. Astana: izdatel´stvo: Evraziyskiy natsional´nyy universitet im. L.N. Gumileva, 2007. S. 128.
17. Makisheva R.T. Formirovanie zashchitno-prisposobitel´nykh sistem pri giperinsulinemii. Materialy 1-y mezhdunarodnoy konferentsii «Valeologicheskie aspekty profilaktiki i lecheniya bolezni». Astana, 1998. S. 270-271.
18. Maskova G.S., Chernaya N.L., Dadaeva O.B. Patogeneticheskie varianty razvitiya disfunktsii endoteliya sosudov u podrostkov s ozhireniem. Vestnik novykh meditsinskikh tekhnologiy (elektronnoe izdanie). 2015. №4. Publikatsiya 2-4. URL: http://www.medtsu.tula.ru/VNMT/Bulletin/E2015-4/5216.pdf (data obrashcheniya 18.11.2015). DOI:12737/14921
19. Oleynik D.S., Makisheva R.T. Vyyavlenie zhalob skrytykh gipoglikemiy u bol´nykh sakharnym diabetom . Elektronnyy sbornik statey po materialam XXXVI studencheskoy mezhdunarodnoy nauchno- prakticheskoy konferentsii (elektronnyy resurs). 2015. №10 (35). URL: http://www.sibac.info /archive/nature/10(35).pdf.
20. Pinkhasov B.B., Selyatitskaya V.G., Shorin Yu.P., Astrakhantseva E.L., Anufrienko E.V. Vliyanie tipa ozhireniya u zhenshchin na urovni glyukozy i insulina v krovi v dinamke peroral´nogo testa na tolerantnost´ k glyukoze. 2011. №9(2). S. 279-282.
21. Romantsova T.I., Ostrovskaya E.V. Metabolicheski zdorovoe ozhirenie: definitsii, protektivnye faktory, klinicheskaya znachimost´. Al´manakh klinicheskoy meditsiny. 2015. №S1. S.75-86.
22. Sergeev P.V., Shimanovskiy N.L., Petrov V.N. Retseptory fiziologicheski aktivnykh veshchestv. Volgograd: Sem´ vetrov, 1999. 640 c.
23. Smirnova O.M., Ivannikova E.V. Terapiya sakharnogo diabeta i risk kantserogeneza. Problemy endokrinologii. 2012. №2. S. 52-57.
24. Shambakh Kh., Knappe G., Karol V. Gormonoterapiya. Perevod s nemetskogo. M.: Meditsina, 1988. 416 s.
25. Bowker S.L., Majumdar S.R., Veugelers P., Johnson J.A. Increased cancer-related mortality for pa-tients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 2006. Vol. 29. P. 254-258.
26. Carmean C.M., Bobe A.M., Yu J.C., Volden P.A., Brady M.J. Refeeding-induced brown adipose tissue glycogen hyper-accumulation in mice is mediated by insulin and catecholamines. PLoS One. 2013. №8(7). e67807. DOI:https://doi.org/10.1371/journal.pone.0067807.
27. Corkey B.E. Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?. Diabetes Care. 2012. №35(12). R. 2432-2437. DOI:https://doi.org/10.2337/dc12-0825.
28. Corkey B.E. Hyperinsulinemia: Cause or Consequence? Banting Lecture 2011. Diabetes. 2012. №61(1). R. 4-13. DOI:https://doi.org/10.2337/db11-1483.
29. Dias T.R., Rato L., Martins A.D., Simões V.L., Jesus T.T., Alves M.G., Oliveira P.F. Insulin deprivation decreases caspase-dependent apoptotic signaling in cultured rat sertoli cells. ISRN Urol. 2013. R. 970370. DOI:https://doi.org/10.1155/2013/970370.
30. Erion K.A., Berdan C.A., Burritt N.E., Corkey B.E., Deeney J.T. Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells. J Biol Chem. 2015. №290(26). R. 16191-16201. DOI:https://doi.org/10.1074/jbc.M114.620351.
31. Guillena C., Bartoloméa A., Nevadoa C., Benito M. Biphasic effect of insulin on beta cell apoptosis depending on glucose deprivation. FEBS Lett. 2008. №582(28). R. 3855-3860.
32. Janket S.J., Manson J.E., Sesso H. Buring JE, Liu S. A prospective study of sugar intake and risk of type 2 diabetes in women. Diabetes Care. 2003. Vol.26. P. 1008-1015.
33. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease / Klein S., Fontana L., Young V.L. [et al.]. N Engl J Med. 2004. №350. R. 2549-2557
34. Lamontagne J., Jalbert-Arsenault E., Pepin E., Peyot M.L., Ruderman N.B., Nolan C.J., Joly E., Madi-raju S.R., Poitout V., Prentki M. Pioglitazone acutely reduces energy metabolism and insulin secretion in rats. Diabetes. 2013. №62(6). R. 2122-2129. DOI:https://doi.org/10.2337/db12-0428.
35. Pal A., Barber T.M., Van de Bunt M., Rudge S.A., Zhang Q., Lachlan K.L., Cooper N.S., Linden H., Levy J.C., Wakelam M.J., Walker L., Karpe F., Gloyn A.L. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med. 2012. №367(11). R. 1002-1011.
36. Palmer A.K., Tchkonia T., LeBrasseur N.K., Chini E.N., Xu M., Kirkland J.L. Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity. Diabetes. 2015. №64(7). R. 2289-2298. DOI:https://doi.org/10.2337/db14-1820.
37. Pories W.J., Dohm G.L. Diabetes: Have We Got It All Wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care. 2012. №35(12). R. 2438-2442. DOI:https://doi.org/10.2337/dc12-0684.
38. Roche E., Maestre I., Martín F., Fuentes E., Casero J., Reig J.A., Soria B. Nutrient toxicity in pancrea-tic beta-celldysfunction. J Physiol Biochem. 2000. №56(2). R. 119-128.
39. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Porte D.Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 1992. Vol. 13, №3. R. 387-414.
40. Van de Casteele M., Kefas B.A., Cai Y., Heimberg H., Scott D.K., Henquin J.C., Pipeleers D., Jonas J.C. Prolonged culture in low glucose induces apoptosis of rat pancreatic beta-cells through induction of c-myc. Biochem Biophys Res Commun. 2003. №312(4). R. 937-944.
41. Wu J., Boström P., Sparks L.M., Ye L., Choi J.H., Giang A.H., Khandekar M., Virtanen K.A., Nuutila P., Schaart G., Huang K., Tu H., van Marken Lichtenbelt W.D., Hoeks J., Enerbäck S., Schrauwen P., Spiegelman B.M. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012. №150(2). R. 366-376.
42. Xu S., Kim J.H., Hwang K.H., Das R., Quan X., Nguyen T.T., Kim S.J., Cha S.K., Park K.S. Autocrine insulin increases plasma membrane KATP channel via PI3K-VAMP2 pathway in MIN6 cells. Biochem Bio-phys Res Commun. 2015. PII: S0006-291X(15)30898-6.
43. Yajnik C.S., Katre P.A., Joshi S.M., Kumaran K., Bhat D.S., Lubree H.G., Memane N., Kinare A.S., Pandit A.N., Bhave S.A., Bavdekar A., Fall C.H. Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune Children´s Study. Diabetologia. 2015. №58(7). R. 1626-1636. DOI:https://doi.org/10.1007/s00125-015-3602-z.
44. Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013. №7(1). R. 14-24. DOI:https://doi.org/10.1007/s11684-013-0262-6.
45. Ye L., Robertson M.A., Mastracci T.L., Anderson R.M. An insulin signaling feedback loop regulates pancreas progenitor cell differentiation during islet development and regeneration. Dev Biol. 2015. PII: S0012-1606(15)30328-6.
46. Zendehdel K., Nyren O., Ostenson C.G. Adami H.O., Ekbom A., Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J. Natl. Cancer Inst. 2003. Vol. 95. P. 1797-1800.
